###begin article-title 0
###xml 73 83 73 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
Kinome-Wide RNAi Screen Implicates at Least 5 Host Hepatocyte Kinases in Plasmodium Sporozoite Infection
###end article-title 0
###begin p 1
Conceived and designed the experiments: MP CDR MH CJE MMM. Performed the experiments: MP CDR CM ER LAG. Analyzed the data: MP CDR MH CM ER CC MMM. Contributed reagents/materials/analysis tools: RD KJH AJFL RWS CJE. Wrote the paper: MP CJE MMM.
###end p 1
###begin p 2
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 128 137 128 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Anopheles</italic>
###xml 561 571 561 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 1087 1097 1083 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 1519 1529 1503 1513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 489 494 <span type="species:ncbi:9606">human</span>
###xml 561 571 <span type="species:ncbi:5821">P. berghei</span>
###xml 1087 1097 <span type="species:ncbi:5821">P. berghei</span>
###xml 1117 1121 <span type="species:ncbi:10090">mice</span>
Plasmodium sporozoites, the causative agent of malaria, are injected into their vertebrate host through the bite of an infected Anopheles mosquito, homing to the liver where they invade hepatocytes to proliferate and develop into merozoites that, upon reaching the bloodstream, give rise to the clinical phase of infection. To investigate how host cell signal transduction pathways affect hepatocyte infection, we used RNAi to systematically test the entire kinome and associated genes in human Huh7 hepatoma cells for their potential roles during infection by P. berghei sporozoites. The three-phase screen covered 727 genes, which were tested with a total of 2,307 individual siRNAs using an automated microscopy assay to quantify infection rates and qRT-PCR to assess silencing levels. Five protein kinases thereby emerged as top hits, all of which caused significant reductions in infection when silenced by RNAi. Follow-up validation experiments on one of these hits, PKCsigma (PKCzeta), confirmed the physiological relevance of our findings by reproducing the inhibitory effect on P. berghei infection in adult mice treated systemically with liposome-formulated PKCsigma-targeting siRNAs. Additional cell-based analyses using a pseudo-substrate inhibitor of PKCsigma added further RNAi-independent support, indicating a role for host PKCsigma on the invasion of hepatocytes by sporozoites. This study represents the first comprehensive, functional genomics-driven identification of novel host factors involved in Plasmodium sporozoite infection.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 38 48 38 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 1017 1027 1017 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 862 867 <span type="species:ncbi:9606">human</span>
###xml 989 994 <span type="species:ncbi:9606">human</span>
During a mammalian malaria infection, Plasmodium sporozoites injected by an infected mosquito travel to the liver where they invade hepatocytes and multiply into thousands of new parasites. These newly formed merozoites are then released into the bloodstream where they infect red blood cells and cause the symptoms of the disease. Although asymptomatic, the liver stage of malaria is an obligatory step in the parasite's lifecycle and constitutes an appealing target for prophylatic intervention. The marked tropism of sporozoites for hepatocytes suggests the latter may provide the parasite with a molecular environment that it can exploit to its own benefit. The identification of host factors that influence hepatic infection can thus provide clues for potential anti-malarial strategies. To this end, we carried out an RNA interference screen of the entire human kinome and associated signaling molecules and assessed the effect of knockdown of their expression in the infection of a human hepatoma cell line by Plasmodium. This strategy identified at least 5 kinases whose down-regulation leads to a marked decrease in infection. Further characterisation of one of these proteins, PKCzeta, confirmed that it plays a role in infection by influencing the parasite's invasion of the host liver cells.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 357 367 357 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 435 444 435 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Anopheles</italic>
Although malaria has long been a devastating killer for the most vulnerable populations in countries of sub-Saharan Africa and other developing nations, our understanding of the early host-parasite interactions underlying this infectious disease remains far from complete. In fact, the first stage of a malaria infection, which occurs in the liver once the Plasmodium parasite has been delivered through the bite of an infected female Anopheles mosquito, is still clearly under-studied today.
###end p 6
###begin p 7
###xml 32 42 32 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 303 306 303 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Prudencio1">[1]</xref>
###xml 503 506 503 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Mota1">[2]</xref>
###xml 593 603 593 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 821 824 821 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Sturm1">[3]</xref>
Once inside the mammalian host, Plasmodium sporozoites, the motile form that is delivered in the mosquito's saliva, display a marked tropism for hepatocytes, the cells that enable the remarkable replication process that will give rise to thousands of merozoites from each invading parasite (reviewed in [1]). As a first step towards infection, several hepatocytes are transiently traversed by the sporozoite before one cell is productively invaded, leading to the formation of a parasitophorous vacuole [2]. Within this cytosolic vacuole, the subsequent development and asexual replication of Plasmodium, constituting so-called exoerythrocytic forms (EEFs), achieve one of the fastest growth rates among all eukaryotic cells. The invaded hepatocyte eventually releases thousands of mature merozoites into the bloodstream [3], where these then invade erythrocytes, thereby initiating the so-called blood stage of infection and triggering the well-known symptoms of malaria. Both the strong tropism and obligate nature of the events that take place during liver infection suggest an essential requirement for hepatocyte-specific factors in enabling this complex lead-up to the blood stage. It is therefore of primary interest to identify and characterize the role of such host factors, as these may contribute to the design of rational interventional strategies for the development of novel prophylactic agents.
###end p 7
###begin p 8
###xml 97 107 97 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 226 236 226 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 268 277 268 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Anopheles</italic>
###xml 342 351 342 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g001">Figure 1A</xref>
###xml 745 748 745 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Hunter1">[4]</xref>
###xml 161 166 <span type="species:ncbi:9606">human</span>
###xml 226 236 <span type="species:ncbi:5821">P. berghei</span>
To this end, we have used a cultured cell-based assay to study the process of liver infection by Plasmodium parasites at the cellular and molecular level. Using human Huh7 hepatoma cells and sporozoites of the rodent parasite P. berghei freshly isolated from infected Anopheles mosquitoes, we have established a high throughput assay system (Figure 1A) that, combined with high content readouts using automated microscopy, and quantitative RT-PCR (qRT-PCR), can be used for RNA interference (RNAi) and/or drug screening experiments. Intracellular phosphorylation and dephosphorylation events are enzymatically catalysed by kinases and phosphatases, respectively, and constitute the most important signalling mechanisms known in eukaryotic cells [4]. The phosphorylation state of a protein can determine its activity and, thereby, regulate the pathway(s) in which it is involved. Thus, the present study probed the potential role of key components of host hepatocyte signal transduction pathways, focusing on kinases as key regulators for a wide range of cellular functions.
###end p 8
###begin title 9
###xml 78 88 78 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
RNA interference screen strategy for identification of host factors affecting Plasmodium infection.
###end title 9
###begin p 10
###xml 95 105 95 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
(A) Experimental design of a high-throughput RNAi screen to identify host genes that influence Plasmodium sporozoite infection of host cells. (B) Validation of siRNA-mediated knock-down in Huh7 cells. Knock-down efficiency of 53 genes was evaluated by qRT-PCR following Huh7 cell transfection with 3 independent siRNAs per targeted gene.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 62 72 62 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 86 91 <span type="species:ncbi:9606">human</span>
Kinome-wide RNAi screen implicates at least 5 host kinases in Plasmodium infection of human hepatoma cells
###end title 12
###begin p 13
###xml 234 242 234 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000201.s001">Table S1</xref>
###xml 323 333 323 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 464 473 464 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g001">Figure 1A</xref>
###xml 677 687 677 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 677 687 <span type="species:ncbi:5821">P. berghei</span>
We have used systematic RNAi screening to selectively silence the expression of 727 genes encoding proteins with known or putative kinase activity, as well as kinase-interacting proteins, thereby covering the entire annotated kinome (Table S1). The effect of each gene-specific knock-down on the infection of Huh7 cells by Plasmodium sporozoites was then monitored using the high-throughput, high-content immunofluorescence microscopy-based assay mentioned above (Figure 1A). Briefly, short interfering RNA duplexes (siRNAs) targeting each of the chosen genes were transfected into Huh7 cells 24 h after seeding in 96-well plates. Forty-eight h later, cells were infected with P. berghei sporozoites. Cells were fixed 24 h after infection and immuno-stained to detect intracellular parasites (EEFs), as well as host cell nuclei and F-actin to estimate cell numbers and confluency, respectively. Following image acquisition, customized image analysis algorithms were used to automatically quantify infection rates, normalizing the number of EEFs against the cell confluency in each well. A plate-wise normalization was also used to facilitate comparisons between plates in the first pass of the screen, where the low rate of positive hits yields minimal expectation of variability in the mean infection values between different plates. To this end, the infection rate in each experimental well was calculated as a percentage of the mean infection rate from all experimental wells on that plate. In order to assess possible siRNA effects on cell proliferation, infection rate data were plotted against the number of nuclei, also expressed as a percentage of the mean number of nuclei for that plate.
###end p 13
###begin p 14
###xml 488 497 488 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g001">Figure 1B</xref>
The RNAi strategy employed was validated by targeting 53 randomly chosen genes with 3 siRNAs each and performing quantitative real-time PCR (qRT-PCR) analysis to determine the level of knock-down achieved in each case. For 13 of these genes either expression was too low to be correctly assessed or primer specificity was insufficient. Most importantly, for 85% of the genes whose expression could be determined, at least 1 of the siRNAs led to an expression knock-down greater than 70% (Figure 1B).
###end p 14
###begin p 15
###xml 412 421 412 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g002">Figure 2A</xref>
###xml 544 552 544 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000201.s001">Table S1</xref>
###xml 961 970 959 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g002">Figure 2B</xref>
Sporozoite infection assays inevitably have considerable levels of variation, a problem that cannot currently be overcome and which exacerbates difficulties generally associated with siRNA screens. In order to reduce the risk of reporting false positives, a multi step screening system was devised in which candidate genes were subjected to three screening passes with increasingly stringent selection criteria (Figure 2A). In the first pass, the 727 selected genes were screened by targeting each with three distinct siRNAs used individually (Table S1). In order to minimize the number of false negative results, candidate gene hits were selected for follow-up in pass 2 if any single one of the three siRNAs yielded an increase or decrease on infection greater than 2 standard deviations (s.d.) of the average of the infection of the whole data set, within a defined range of nuclei number (+/-40% of the average number of nuclei in each experimental plate) (Figure 2B). The latter precaution, while relatively inclusive, allowed us to exclude from further analysis those siRNAs yielding strong effects on cell proliferation or survival.
###end p 15
###begin title 16
###xml 63 73 63 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 63 73 <span type="species:ncbi:5821">P. berghei</span>
A kinome-wide RNAi screen identifies host genes that influence P. berghei sporozoite infection of Huh7 cells.
###end title 16
###begin p 17
###xml 223 233 223 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 1069 1079 1065 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 1873 1883 1865 1875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 2021 2030 2013 2022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g002">Figure 2F</xref>
###xml 2470 2476 2458 2464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 185 190 <span type="species:ncbi:9606">human</span>
###xml 223 233 <span type="species:ncbi:5821">P. berghei</span>
###xml 1031 1036 <span type="species:ncbi:9606">human</span>
###xml 1069 1079 <span type="species:ncbi:5821">P. berghei</span>
###xml 1835 1840 <span type="species:ncbi:9606">human</span>
###xml 1873 1883 <span type="species:ncbi:5821">P. berghei</span>
(A) Schematic illustration of the three screening passes with increasing stringency criteria. (B) Plot of pass 1 of the RNAi screen representing the effect of 2181 siRNAs targeting 727 human genes on Huh7 cell infection by P. berghei sporozoites and cell nuclei count. Infection rates for each experimental condition were normalized against cell confluency. The horizontal lines represent 100%+/-2.0 s.d. of the average of all infection data in the assay. Each circle represents one siRNA (mean of triplicate values). Negative controls appear as blue and green circles. corresponding to untreated cells and cells transfected with a non-specific control siRNA. respectively. Red circles highlight the siRNAs targeting the 73 candidate genes selected to undergo a second screening pass. The shaded areas correspond to cell numbers outside the +/-40% interval centred on the average number of nuclei for the whole dataset. (C) Plot of 2 independent runs of pass 2 of the RNAi screen representing the effect of 227 siRNAs targeting 73 human genes on Huh7 cell infection by P. berghei sporozoites and cell nuclei count. Shading and colour attributions are the same as in panel (B). with red circles representing the siRNAs targeting the 16 genes selected to undergo a third screening pass. The horizontal lines represent 100%+/-2.0 s.d. of the average of all the negative controls in the assay. (D) Plot comparison of the 2 runs of pass 2 of the RNAi screen. Colour attributions are the same as in panels (B. C). The comparison reveals a high correlation (R = 0.88) between the duplicate runs of pass 2 of the screen (diagonal line). The horizontal and vertical lines represent 100%+/-2.0 s.d. of the average of all the negative controls in the assay. (E) Plot of pass 3 of the RNAi screen representing the effect of 37 siRNAs targeting 16 human genes on Huh7 cell infection by P. berghei sporozoites and cell nuclei count. Remaining mRNA levels following RNAi were determined for each of these genes by qRT-PCR (see text and Figure 2F). Colour attributions and shading are the same as in (B. C. D). Red circles highlight siRNAs targeting the genes for which at least two independent siRNAs led to an infection increase or decrease above or below +/-3.0 s.d. of the average of all the negative controls in the assay. respectively. The horizontal lines represent 100%+/-3.0 s.d. of the average of all the negative controls in the assay. (F) Effect of siRNA on infection rates versus remaining mRNA levels for the 7 genes targeted by the siRNAs highlighted in red in (E). Each circle represents one siRNA (mean of triplicate values). For all genes except GUK1 and HCK. represented in light grey. a positive correlation between infection rate and remaining gene-specific mRNA levels is observed. Shading attributions are the same as in (B. C. E). The horizontal lines represent the same as in E (100%+/-3.0 s.d. of the average of all the negative controls in the assay). The axes on the bottom left of the panel denote the scale of each of the plots in the panel.
###end p 17
###begin p 18
###xml 243 251 243 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000201.s001">Table S1</xref>
###xml 919 928 919 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g002">Figure 2C</xref>
###xml 1275 1284 1275 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g002">Figure 2D</xref>
As a result, 73 genes were selected to undergo a second pass of confirmation screening, in which up to 2 additional siRNAs were included to maximize the detection sensitivity for those genes that had yielded only a single siRNA hit in pass 1 (Table S1). In this round of analysis, siRNAs were noted as "positive candidates" if they yielded infection rates more than 2 s.d. above or below the mean of all the negative controls in this pass. Negative controls replaced whole data set mean for s.d. calculation, since the selected subset of genes in this pass 2 was expected to have a significantly higher hit rate than in pass 1. To minimize the risk of false positives due to siRNA sequence-dependent off-target effects, the selection of candidate genes for follow-up beyond pass 2 required that at least two independent siRNAs targeting the same gene be "positive candidates" according to the above selection criteria (Figure 2C). Furthermore, genes for which different siRNAs yielded conflicting phenotypic results were also excluded from further analysis. In order to further minimize any bias due to experimental variability, all pass 2 siRNAs were assayed in two independent experiments, and were selected for follow-up only if the criteria were met in both experiments (Figure 2D). It is worthwhile noting that while in Pass 1 only 3.6% of the siRNAs met the selection threshold, 18.4% of the siRNAs tested for the first time in Pass 2 met similar criteria, while the distribution of infection levels in controls is not statistically different between pass 1 and pass 2 experiments, showing that a 5-fold enrichment has taken place from Pass 1 to Pass 2.
###end p 18
###begin p 19
###xml 411 420 411 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g002">Figure 2E</xref>
###xml 733 742 733 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g002">Figure 2F</xref>
###xml 744 751 744 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000201-t001">Table 1</xref>
The 16 genes thus selected for further verification in pass 3 were targeted with the siRNAs yielding the strongest phenotypes in the second pass. This third pass was used to further restrict our selection to those genes showing clearest functionality, i.e. those with at least two siRNAs yielding infection rates more than 3 s.d. above or below the mean of all the negative controls in the assay, respectively (Figure 2E). Secondly, target mRNA knock-down levels attained for these genes were also assessed in this pass by qRT-PCR. This allowed the selection of positive hit candidates to be refined further yet by excluding genes for which a correlation between phenotypic severity and decreased mRNA levels could not be confirmed (Figure 2F, Table 1).
###end p 19
###begin title 20
List of genes in Pass 3 of the RNAi screen.
###end title 20
###begin p 21
Ambion, Applied Biosystems.
###end p 21
###begin p 22
Number of cell nuclei, shown as % of plate mean.
###end p 22
###begin p 23
Number of EEFs normalised to confluency, shown as % of plate mean.
###end p 23
###begin p 24
% relative to negative control.
###end p 24
###begin p 25
Average of infection rates for the selected siRNAs.
###end p 25
###begin p 26
n.d. - not determined.
###end p 26
###begin p 27
###xml 216 226 216 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 335 344 332 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000201.s002">Figure S1</xref>
###xml 485 492 482 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000201-t001">Table 1</xref>
###xml 688 691 685 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Echeverri1">[5]</xref>
###xml 906 914 903 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000201.s001">Table S1</xref>
###xml 216 226 <span type="species:ncbi:5821">P. berghei</span>
Based on these data, the following 5 genes have emerged from our screen as the clearest and strongest positive hits, showing RNAi-induced loss-of-function phenotypes with specific, reproducible and marked effects on P. berghei infection rates in our Huh7-based assay: MET, PKCzeta (PKCzeta), PRKWNK1, SGK2 and STK35. As illustrated in Figure S1, knock-down of the expression of these genes did not lead to any significant effects in terms of cell proliferation or morphology (see also Table 1). It should also be noted that the present data do not rule out the possible involvement of other genes among those tested here, since negative results in RNAi screens are generally inconclusive [5], and certain genes showing phenotypes with lower than 3 s.d. from mean levels in our assays may provide real, though perhaps more subtle, functionalities in this context. For this reason, the reader is referred to Table S1 for a comprehensive list of siRNAs employed throughout the screen and their corresponding z scores (which measure the number of standard deviations away from the mean for the whole normalized data set), obtained throughout the screen.
###end p 27
###begin title 28
Top screening hits classification
###end title 28
###begin p 29
###xml 158 161 158 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Manning1">[6]</xref>
###xml 188 198 188 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000201.s003">Figure S2A</xref>
###xml 677 687 677 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000201.s003">Figure S2B</xref>
###xml 784 790 784 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 790 793 790 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Agaisse1">[7]</xref>
###xml 814 824 814 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 1007 1008 1007 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1353 1363 1353 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000201.s003">Figure S2C</xref>
###xml 814 824 <span type="species:ncbi:7227">Drosophila</span>
It may be noted that all five genes we identified as top hits encode protein kinases belonging to 3 different classes, according to the kinome classification [6]: "AGC", "other" and "TK" (Figure S2A). While it is tempting to draw conclusions from this, we would advise against it since, as aforementioned, the experimental methods and prioritization strategies used here cannot conclusively rule out the involvement of other tested genes which did not make the final selection. The range of cellular processes implicated by the genes identified as top hits in the present screen include cell cycle control, cytoskeleton regulation, osmotic balance and stress/immune responses (Figure S2B). This is consistent with the broad range of cellular functions similarly implicated by Agaisse et al.[7] in the infection of Drosophila cells by intracellular bacterial pathogens. However, when we performed an hypergeometric test to identify which Gene Ontology (GO) terms were significantly enriched in the analysis (p<0.05), not all categories were equally represented in passes 2 and 3 with a major proportion of genes involved in cytoskeleton regulation. Interestingly, amongst the five final hits, we could observe a complete shift of representation, as a 50/50 segregation was observed for genes related to stress/immune responses and to cell cycle control (Figure S2C).
###end p 29
###begin title 30
###xml 65 75 62 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
PKCzeta inhibition leads to a decrease in host cell infection by Plasmodium sporozoites
###end title 30
###begin p 31
###xml 427 430 424 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Duran1">[8]</xref>
###xml 431 434 428 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-McConkey1">[9]</xref>
###xml 604 608 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Mellor1">[10]</xref>
###xml 666 670 660 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Moscat1">[11]</xref>
###xml 694 698 685 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Ono1">[12]</xref>
###xml 737 741 720 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Akimoto1">[13]</xref>
###xml 915 919 894 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Moscat1">[11]</xref>
###xml 920 924 899 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Moscat2">[14]</xref>
###xml 925 929 904 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Suzuki1">[15]</xref>
###xml 186 191 <span type="species:ncbi:9606">human</span>
In order to further characterize the functionalities identified in our cell-based infection model and to validate their relevance both from a physiological point of view and in terms of human malaria, we have initiated detailed follow-up studies for all 5 of the top hits from our RNAi screen, and present herein results for PKCzeta, the first of these to be prioritized due to its role in several liver pathological processes [8],[9]. PKCzeta is part of the large family of PKCs, which has been implicated in a wide range of cellular processes. PKC isotypes include 10-15 members, divided into 4 groups [10]. One of these groups, known as the atypical PKCs (aPKCs) [11], comprises the PKCzeta [12] and PKClambda/iota (PKC lambda/iota ) [13] isoforms. The aPKCs have been implicated in numerous processes, including cell growth and survival, regulation of NF-kappaB (NF-kappaB) activation and polarity (reviewed in [11],[14],[15]).
###end p 31
###begin p 32
###xml 142 146 142 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Newton1">[16]</xref>
###xml 186 194 186 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-House1">[17]</xref>
###xml 474 478 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Laudanna1">[18]</xref>
###xml 479 483 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Standaert1">[19]</xref>
###xml 488 498 479 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 568 577 556 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000201.s004">Figure S3</xref>
###xml 670 674 655 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Laudanna1">[18]</xref>
###xml 814 825 796 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g003">Figure 3A&#8211;C</xref>
###xml 920 929 899 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000201.s002">Figure S1</xref>
###xml 931 938 910 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000201-t001">Table 1</xref>
###xml 1042 1052 1018 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 1116 1126 1092 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 1168 1177 1144 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g003">Figure 3D</xref>
###xml 1218 1227 1194 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g003">Figure 3E</xref>
###xml 1257 1267 1233 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 1427 1437 1372 1382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 1516 1531 1461 1476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g003">Figure 3D and E</xref>
###xml 1533 1534 1478 1479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1544 1545 1489 1490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1644 1654 1586 1596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 488 498 <span type="species:ncbi:5821">P. berghei</span>
###xml 1042 1052 <span type="species:ncbi:5821">P. berghei</span>
###xml 1183 1188 <span type="species:ncbi:10090">mouse</span>
###xml 1257 1267 <span type="species:ncbi:5821">P. berghei</span>
###xml 1427 1437 <span type="species:ncbi:5821">P. berghei</span>
###xml 1644 1654 <span type="species:ncbi:5821">P. berghei</span>
All PKC isoenzymes have an autoinhibitory pseudosubstrate domain sequence that can bind to the substrate-binding cavity and prevent catalysis [16]. This inhibtory effect can be mimicked in vitro by addition of a corresponding synthetic peptide [17]. Thus, we used the cell-based assay described above for our screen to test the effects of a myristoylated PKCzeta pseudosubstrate (myr-SIYRRGARRWRKLYRAN), previously characterized as a specific PKCzeta inhibitor (PKCzetaInh) [18],[19], on P. berghei infection. Further data on the specificity of PKCzetaInh is shown in Figure S3. A scrambled myristolated peptide was used as control in all PKCzeta inhibition experiments [18]. Treatment of cells with PKCzetaInh had no obvious effects on nuclear or cell morphology and as well as on the cell number and confluency (Figure 3A-C), as previously observed for cells transfected with siRNA oligonucleotides targeting PKCzeta (Figure S1, Table 1). Still, treatment of cells with PKCzetaInh had a significant effect in the level of cell infection by P. berghei sporozoites, as quantified using qRT-PCR-based measurements of Plasmodium 18S rRNA levels found within Huh7 cells (Figure 3D) and mouse primary hepatocyte extracts (Figure 3E) harvested 24 and 48 h after P. berghei sporozoite addition, respectively. Our results show that a 20 microM concentration of PKCzetaInh leads to a approximately80% and approximately60% reduction in P. berghei infection rates in Huh7 hepatoma cells and primary hepatocytes, respectively (Figure 3D and E; p<0.01 and p<0.05), offering a RNAi-independent confirmation of our present findings on the role of PKCzeta in P. berghei infection.
###end p 32
###begin title 33
PKCzeta inhibition by a pseudosubstrate decreases hepatocyte infection without affecting host cell viability.
###end title 33
###begin p 34
###xml 450 460 437 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 450 460 <span type="species:ncbi:5821">P. berghei</span>
###xml 488 493 <span type="species:ncbi:10090">mouse</span>
(A) Representative pictures of cells treated with the PKCzeta pseudosubstrate inhibitor and a control peptide. The pictures depict nuclei (in blue) and actin (in red) and show that cells are not affected by the inhibitor peptide. (B. C) Quantification of cell confluency (B) and number of nuclei (C) in 40 microscope fields of cells treated with the PKCzeta pseudosubstrate inhibitor and a control peptide. (D. E) Effect of PKCzetaInh (20 microM) on P. berghei load in Huh7 cells (D) and mouse primary hepatocytes (E). Parasite loads were measured by qRT-PCR 24 h or 48 h after sporozoite addition. respectively. Results are expressed as the mean+/-s.d. of triplicate samples. Cells treated with a myristoylated scrambled peptide were used as controls in each experiment. Infection loads are normalized to the corresponding control infection levels (100%).
###end p 34
###begin title 35
###xml 56 66 53 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
Inhibition of PKCzeta impairs invasion of host cells by Plasmodium sporozoites
###end title 35
###begin p 36
###xml 275 285 269 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 328 329 322 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 336 340 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Prudencio2">[20]</xref>
###xml 548 558 542 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 589 593 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Prudencio2">[20]</xref>
###xml 675 685 666 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 866 875 857 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g004">Figure 4A</xref>
###xml 877 878 868 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 953 963 932 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 1047 1056 1026 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g004">Figure 4B</xref>
###xml 1422 1426 1401 1405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Prudencio2">[20]</xref>
###xml 1520 1529 1499 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g004">Figure 4C</xref>
###xml 1742 1752 1715 1725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 1766 1767 1739 1740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1942 1951 1903 1912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g004">Figure 4D</xref>
###xml 2134 2144 2089 2099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 2263 2273 2218 2228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 2426 2435 2375 2384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g004">Figure 4E</xref>
###xml 2759 2768 2702 2711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g004">Figure 4F</xref>
###xml 2955 2956 2898 2899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 3233 3243 3173 3183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 275 285 <span type="species:ncbi:5821">P. berghei</span>
###xml 675 685 <span type="species:ncbi:5821">P. berghei</span>
###xml 1742 1752 <span type="species:ncbi:5821">P. berghei</span>
###xml 3233 3243 <span type="species:ncbi:5821">P. berghei</span>
In order to gain a better insight on the possible role of PKCzeta in the infection process, the effects of PKCzetaInh on different periods of hepatocyte infection were examined by flourescence activated cell sorting (FACS) analysis of host cells infected with GFP-expressing P. berghei parasites, measuring the proportion of GFP+ cells [20]. Indeed, FACS analysis of cells infected with GFP-expressing parasites enables discerning whether the observed effect on infection is due to a decrease in the number of infected cells or to an impairment of Plasmodium development inside host cells [20]. Treatment of Huh7 cells with PKCzetaInh 1 h prior to addition of GFP-expressing P. berghei sporozoites led to a marked, dose-dependent decrease in infection rate, as measured by the proportion of infected cells relative to control samples 24 h after sporozoite addition (Figure 4A; p<0.05 for PKCzetaInh>/=5 microM). Treatment with PKCzetaInh did not affect Plasmodium development, as shown by the similar GFP intensities of treated and control cells (Figure 4B). Next, we sought to determine whether the decrease in the number of infected cells observed at 24 h after sporozoite addition was due to a decrease in invasion rate or to the disappearance of infected cells throughout infection. Since, in the infection assay employed, >95% of invasion events are known to take place within the first 2 h after sporozoite addition [20], any effects on invasion can be quantified by analyzing cells at this timepoint. As shown in Figure 4C, the effect of PKCzetaInh in cells analyzed 2 h after sporozoite addition is closely comparable to that seen with the full 24 h treatment, indicating that PKCzeta likely plays a role during host cell invasion by P. berghei sporozoites (p<0.05 for PKCzetaInh>/=5 microM). In addition, when PKCzetaInh was added 2 h after sporozoite addition, no significant effect was observed in infection rate measured at 24 h (Figure 4D), not only showing that the effect observed on the early steps of infection is not due to PKCzetaInh toxicity to host cells but also strengthening the notion that PKCzeta influences Plasmodium infection by playing a role during cell invasion. Importantly, infection rates were not affected by pre-incubation of Plasmodium sporozoites with PKCzetaInh for 1 hour prior to their addition to hepatoma cells, showing that PKCzetaInh has no direct effect on sporozoite viability (Figure 4E). Further confirmation of the involvement of PKCzeta in sporozoite invasion of Huh7 cells, but not on the parasite's intracellular development was obtained by employing qRT-PCR to quantify infection 24 h after infection of cells incubated with PKCzetaInh either during the invasion or the development periods, exclusively (Figure 4F). These results show that a marked decrease in intracellular parasite numbers is observed when cells are incubated with the inhibitor during the first 2 hours after sporozoite addition (p<0.001), whereas no effect is observed when the compound is added after invasion is completed. Together, these data confirm the physiological relevance of PKCzeta, identified in the RNAi screen, and suggest that the latter plays a role during the invasion of hepatoma cells by P. berghei sporozoites.
###end p 36
###begin title 37
###xml 56 66 53 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
Inhibition of PKCzeta impairs invasion of host cells by Plasmodium sporozoites.
###end title 37
###begin p 38
###xml 47 57 41 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 194 204 185 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 412 422 394 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 567 577 543 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 713 723 686 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 938 948 905 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 1278 1279 1237 1238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 47 57 <span type="species:ncbi:5821">P. berghei</span>
###xml 194 204 <span type="species:ncbi:5821">P. berghei</span>
###xml 412 422 <span type="species:ncbi:5821">P. berghei</span>
###xml 567 577 <span type="species:ncbi:5821">P. berghei</span>
###xml 713 723 <span type="species:ncbi:5821">P. berghei</span>
###xml 938 948 <span type="species:ncbi:5821">P. berghei</span>
(A) PKCzeta inhibition by PKCzetaInh decreases P. berghei sporozoite infection of Huh7 cells in a dose-dependent manner. PKCzetaInh was added to Huh7 cells 1 h before addition of GFP-expressing P. berghei sporozoites and infection rate was measured 24 h later by FACS. (B) PKCzeta inhibition by PKCzetaInh does not affect EEF development. PKCzetaInh was added to Huh7 cells 1 h before addition of GFP-expressing P. berghei sporozoites and GFP intensity (proportional to EEF development) was measured 24 h later by FACS. (C) PKCzeta inhibition by PKCzetaInh decreases P. berghei sporozoite invasion of Huh7 cells in a dose-dependent manner. PKCzetaInh was added to Huh7 cells 1 h before addition of GFP-expressing P. berghei sporozoites and infection rate was measured 2 h later. by FACS. (D) PKCzeta inhibition does not affect infection after invasion has occurred. PKCzetaInh was added to Huh7 cells 2 h after addition of GFP-expressing P. berghei sporozoites and infection rate was measured 24 h later. by FACS. (E) PKCzetaInh does not affect infection by acting on sporozoites directly. Sporozoites were pre-treated with PKCzetaInh for 1 hour before addition to the cells and infection rate was measured 24 h later by FACS. All results are expressed as the mean+/-s.d. of GFP+ cells (%) in 3 independent infections. (F) PKCzeta inhibition during the period of cell invasion by sporozoites. but not during their intracellular development period. leads to a decrease in infection. The infection rate was determined by qRT-PCR in Huh7 cells incubated with PKCzetaInh throughout different periods of the infection process. namely -1 to 2 h and 2 h to 24 h relative to sporozoite addition.
###end p 38
###begin title 39
###xml 109 116 103 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 22 27 <span type="species:ncbi:10090">mouse</span>
PKCzeta knock-down in mouse livers confirms the physiological relevance of PKCzeta role in malaria infection in vivo
###end title 39
###begin p 40
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 250 260 247 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 274 281 271 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 560 564 557 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Akinc1">[21]</xref>
###xml 565 569 562 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Rodrigues1">[23]</xref>
###xml 787 797 784 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 1296 1305 1290 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000201.s005">Figure S4</xref>
###xml 1591 1600 1564 1573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g005">Figure 5A</xref>
###xml 1602 1603 1575 1576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1834 1844 1792 1802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 1926 1935 1884 1893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g005">Figure 5A</xref>
###xml 1937 1938 1895 1896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 2195 2204 2147 2156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g005">Figure 5A</xref>
###xml 2206 2207 2158 2159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 2555 2564 2489 2498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000201.s006">Figure S5</xref>
###xml 2566 2567 2500 2501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 2779 2788 2710 2719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g005">Figure 5B</xref>
###xml 2998 3007 2926 2935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g005">Figure 5B</xref>
###xml 3009 3010 2937 2938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 3200 3209 3128 3137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000201-g005">Figure 5B</xref>
###xml 3211 3212 3139 3140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 3359 3369 3284 3294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 3403 3411 3328 3336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 3427 3434 3352 3359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 250 260 <span type="species:ncbi:5821">P. berghei</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
###xml 787 797 <span type="species:ncbi:5821">P. berghei</span>
###xml 811 815 <span type="species:ncbi:10090">Mice</span>
###xml 1142 1146 <span type="species:ncbi:10090">mice</span>
###xml 1351 1356 <span type="species:ncbi:10090">mouse</span>
###xml 1834 1844 <span type="species:ncbi:5821">P. berghei</span>
###xml 2351 2355 <span type="species:ncbi:10090">mice</span>
###xml 2531 2535 <span type="species:ncbi:10090">mice</span>
###xml 2621 2625 <span type="species:ncbi:10090">mice</span>
###xml 2773 2777 <span type="species:ncbi:10090">mice</span>
###xml 2848 2852 <span type="species:ncbi:10090">mice</span>
###xml 2920 2924 <span type="species:ncbi:10090">mice</span>
Finally, we tested the in vivo physiological relevance of our cell-based findings more thoroughly by using systemically-delivered, liposome-formulated siRNAs designed to specifically silence PKCzeta expression in adult mice, and infecting these with P. berghei sporozoites. In vivo RNAi treatments using the same systemic administration of siRNAs including the same formulation used here have previously been shown to yield potent gene-specific knock-downs in adult mice without major toxicity, nor any detectable disruption of the endogenous microRNA pathway [21]-[23]. In our present experiments, mice from the same litter were given an initial intravenous (i.v.) injection of either test or control siRNAs and, infection was initiated 36 h later by i.v. injection of freshly isolated P. berghei sporozoites. Mice were sacrificed 40 h after infection to permit parallel analyses of gene silencing and infection load. In order to address the risk of sequence-dependent off-target effects, three distinct siRNA sequences targeting PKCzeta were tested individually, while a siRNA targeting luciferase, a transcript known to be absent in these mice, was used to address sequence-independent off-target effects that may arise from these treatments. Under these conditions, no toxicity was observed (Figure S4) and PKCzeta expression was reduced in adult mouse livers when using each of the 3 distinct PKCzeta-specific siRNAs, yielding an average of approximately56-73% remaining PKCzeta mRNA, as measured by qRT-PCR of liver extracts taken 76 h after siRNA treatment, relative to the controls (Figure 5A; p<0.05). This silencing was accompanied, for all three PKCzeta-specific siRNAs, by significant reductions in liver infection, yielding an average per siRNA of approximately9-40% of control infection loads, as measured by qRT-PCR of P. berghei 18S rRNA in liver extracts taken 76 h after siRNA treatment, as described above (Figure 5A, p<0.05). The reductions in liver infection load showed a broad correlation with the level of PKCzeta silencing achieved by the siRNAs with siRNA #1, which leads to the most significant reduction in PKCzeta, showing the most striking difference in infection (Figure 5A; p<0.01). In a further, parallel experiment, semi-quantitative Western blotting analysis of liver extracts taken 76 h after siRNA treatment, from mice injected with the PKCzeta siRNA yielding the strongest reduction in liver infection, confirmed that PKCzeta expression was significantly reduced at the protein level in these mice (approximately55%; Figure S5, p<0.01). Additionally, another 3 independent groups of mice treated with the same 3 distinct PKCzeta siRNAs showed a decrease in blood parasitaemia (percentage of infected erythrocytes), relative to control mice (Figure 5B). In fact, while by day 4 after sporozoite injection all 5 mice in the control group were positive for blood stages, none of the 6 mice in the group pre-treated with the strongest PKCzeta-specific siRNA were (Figure 5B; p<0.001). Although less striking, both other siRNAs also led to a delay in the appearance of parasites in the blood and siRNA #2 led to a significant reduction in average blood parasitaemia (Figure 5B; p<0.05). Together, these data strongly support the conclusion that PKCzeta is a physiologically important host factor needed for the liver stage of Plasmodium infection both in cultured cells in vitro and in animals in vivo.
###end p 40
###begin title 41
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 59 69 56 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
In vivo PKCzeta down-modulation reduces liver infection by Plasmodium sporozoites confirming the physiological relevance of RNAi screen results.
###end title 41
###begin p 42
###xml 29 36 29 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 50 57 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKC&#950;</italic>
###xml 86 96 83 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 699 706 688 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKC&#950;</italic>
###xml 1146 1153 1129 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKC&#950;</italic>
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
###xml 86 96 <span type="species:ncbi:5821">P. berghei</span>
###xml 243 247 <span type="species:ncbi:10090">Mice</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
###xml 576 580 <span type="species:ncbi:10090">mice</span>
###xml 642 646 <span type="species:ncbi:10090">mice</span>
###xml 715 719 <span type="species:ncbi:10090">mice</span>
###xml 958 963 <span type="species:ncbi:10090">mouse</span>
###xml 1014 1018 <span type="species:ncbi:10090">mice</span>
###xml 1089 1093 <span type="species:ncbi:10090">mice</span>
###xml 1162 1166 <span type="species:ncbi:10090">mice</span>
(A) Effect of siRNA-mediated in vivo silencing of PKCzeta on mouse liver infection by P. berghei (solid bars) and on PKCzeta mRNA levels (dashed bars). measured by qRT-PCR analysis of liver extracts taken 40 h after sporozoite i.v. injection. Mice were infected 36 h after RNAi treatment. Results are plotted as the percentage of the mean of negative control samples. "C". The remaining mRNA levels for PKCzeta were measured by qRT-PCR in the same liver samples. Results are expressed as the mean+/-s.d. of all mice in each group. Black bars represent the negative control (5 mice treated with luciferase-targeting siRNA). Red bars represent mice treated with the 3 independent siRNAs targeting the PKCzeta gene (6 mice per siRNA). (B) Knock-down of PKCzeta expression by RNAi delays the onset of blood stage infection. as measured by parasitemia (percentage of infected red blood cells. iRBC) quantification using flow cytometry. Each symbol represents one mouse. Black circles represent the negative controls (5 mice treated with luciferase-targeting siRNA). Red symbols represent the 6 mice treated with the 3 independent siRNAs targeting the PKCzeta gene (6 mice per siRNA).
###end p 42
###begin title 43
Discussion
###end title 43
###begin p 44
###xml 171 181 171 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 203 211 203 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 879 887 879 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000201.s001">Table S1</xref>
###xml 144 149 <span type="species:ncbi:9606">human</span>
The approach described here constitutes, to our knowledge, the first report of a genome-scale RNAi screen for key host factors for infection of human cells by a parasite. Plasmodium sporozoite infection in vitro assays are fraught with specific biological variability issues that enhance the difficulties inherent to any high-throughput RNAi screening assay. Thus, in order to minimize the chance of excluding false negative and identifying false positive results, we have devised a multi-step strategy employing increasingly stringent selection criteria throughout the screen. Nevertheless, we cannot definitively rule out the possibility of, in this process, having discarded candidates that may indeed play a role during infection, but which did not "survive" the criteria employed throughout the three stages of selection. For this reason, we encourage the reader to consult Table S1, where details of the screening process are presented and potentially relevant genes can be identified.
###end p 44
###begin p 45
###xml 432 442 429 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 31 36 <span type="species:ncbi:9606">human</span>
Our systematic analysis of the human kinome in the context of the liver stage of malaria infection has directly implicated at least five host kinases in this process: MET, PRKWNK1, SGK2, STK35 and PKCzeta. By doing so through direct functional tests for each of the genes assayed, this dataset establishes clear causal roles in the processes examined and reveals novel key host molecules in these pathways that significantly affect Plasmodium's success in infecting hepatocytes.
###end p 45
###begin p 46
###xml 152 162 152 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 188 192 188 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Carrolo1">[24]</xref>
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Leiriao1">[25]</xref>
###xml 273 277 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Leiriao1">[25]</xref>
###xml 401 411 401 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 508 512 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Carrolo1">[24]</xref>
###xml 882 883 882 883 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 889 890 889 890 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 910 914 910 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Anselmo1">[26]</xref>
###xml 915 919 915 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Moriguchi1">[29]</xref>
###xml 1081 1091 1081 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 1353 1354 1353 1354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1401 1405 1401 1405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Kumar1">[30]</xref>
###xml 1479 1480 1479 1480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1661 1665 1661 1665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Vallenius1">[31]</xref>
###xml 1785 1789 1785 1789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Vallenius1">[31]</xref>
###xml 1902 1912 1902 1912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 1923 1927 1923 1927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Carrolo1">[24]</xref>
###xml 2018 2028 2018 2028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
Among our top hits, the MET gene, which encodes the hepatocyte growth factor (HGF) receptor, is the only one to have been previously shown to influence Plasmodium infection of hepatocytes [24],[25], an effect that has been proposed to occur through inhibition of apoptosis [25]. It has been demonstrated that transfection of hepatoma cells with a dominant-negative form of MET leads to a reduction in Plasmodium infection while transfection with a constitutively active form results in an infection increase [24]. Thus, the emergence of MET as one of our top hits whose knock-down consistently led to a decrease in infection represents a validation of the screening methodology used here, and strengthens the predictive value of the other hits. Among those, both SGK2 and PRKWNK1 are serine/threonine kinases that have been implicated in osmotic control through the regulation of Na+ and K+ transport channels [26]-[29]. Down-modulation of both of these osmotic and oxidative stress-responsive proteins also led to a reduced infection in the present screen. Although their role in Plasmodium infection remains unclear, the present data may be highlighting the importance of maintaining an optimal osmotic balance in the host cell to permit successful infection. In addition, it has recently been shown that exposure of sporozoites to the intracellular K+ concentration enhances sporozoite infectivity [30]. Whether or not SGK2 or PRKWNK1 act on infection through the control of K+ concentration will require further investigation. Concerning STK35, it is known to interact with CLP-36, a PDZ-LIM protein, and re-localize from the nucleus to actin stress fibres [31]. This has led to the suggestion that STK35 may act as a regulator of the actin-myosin cytoskeleton in non-muscle cells [31]. Indeed, there are indications that the reorganization of the host cell actin cytoskeleton may be important for Plasmodium infection [24]. Thus, it is appealing to consider the hypothesis that recruitment of STK35 may influence Plasmodium infection by playing a role in this process.
###end p 46
###begin p 47
###xml 227 231 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Mellor1">[10]</xref>
###xml 232 236 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Newton1">[16]</xref>
###xml 294 298 291 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Moscat1">[11]</xref>
###xml 322 326 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Ono1">[12]</xref>
###xml 363 367 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Akimoto1">[13]</xref>
###xml 529 533 511 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Moscat1">[11]</xref>
###xml 534 538 516 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Moscat2">[14]</xref>
###xml 539 543 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Suzuki1">[15]</xref>
###xml 598 606 577 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 611 618 590 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1266 1276 1236 1246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 1398 1408 1368 1378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 1485 1495 1455 1465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
Finally, the gene which we have characterized in most detail here, PKCzeta, is part of the large family of PKCs that has been implicated in numerous cellular processes. PKC isotypes include 10-15 members, divided into 4 groups [10],[16]. One of these groups, known as the atypical PKCs (aPKCs) [11], comprises the PKCzeta [12] and PKClambda/iota (PKCiota/lambda) [13] isoforms. The aPKCs have been implicated in numerous processes, including cell growth and survival, regulation of NF-kappaB activation and polarity (reviewed in [11],[14],[15]). In the present study, loss of PKCzeta function both in vitro and in vivo, whether by RNAi silencing or by pseudo-substrate inhibition, led to decreased infection rates. This unequivocally establishes a key role of PKCzeta in host liver malarial infection, thereby, giving confidence that the other genes identified in the RNAi screen also play a relevant role during infection. Furthermore, as we gain additional understanding of the pathway defined by PKCzeta in this context, its potential biomedical value may develop not merely as one, but rather also as the founding member in an entirely novel class of anti-malarial drug target. In addition, our data reveals a role for PKCzeta signaling in host cell invasion by Plasmodium sporozoites. To our knowledge, this is the first host cell signaling molecule to be identified as an important player in Plasmodium invasion and paves the way to a better understanding of this essential host-Plasmodium interaction in the establishment of a malaria infection.
###end p 47
###begin p 48
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Wang1">[32]</xref>
###xml 414 418 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Zhao1">[33]</xref>
###xml 543 553 543 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 343 360 <span type="species:ncbi:11103">hepatitis C virus</span>
The interaction of a pathogen with its host cell activates intracellular signaling cascades that regulate innate immune responses and govern the outcome of infection (see [32] for a recent review on this topic). These signaling pathways may also be exploited by the pathogen to its own benefit as was recently suggested for the interaction of hepatitis C virus, another major liver pathogen, with its target cells [33]. While our present study does not demonstrate any active exploitation or modulation of host signal transduction pathways by Plasmodium, it does reveal novel key host molecules in these pathways that significantly affect the parasite's success in infecting hepatocytes. Our efforts are thus starting to yield crucial molecular details needed to build a coherent picture of the key cellular events taking place during the liver phase of malaria infection.
###end p 48
###begin p 49
Altogether, these results contribute toward a better understanding of host-pathogen interactions, which may help in accelerating the rational design of prophylactic, therapeutic and/or diagnostic strategies aimed to control malaria.
###end p 49
###begin title 50
Methods
###end title 50
###begin title 51
###xml 7 11 <span type="species:ncbi:10090">Mice</span>
Cells, Mice and Parasites
###end title 51
###begin p 52
###xml 348 349 342 343 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 97 101 <span type="species:ncbi:9913">calf</span>
Huh7 cells, a human hepatoma cell line, were cultured in RPMI medium supplemented with 10% fetal calf serum (FCS, Gibco/Invitrogen), 1% non-essential amino acid (Gibco/Invitrogen), 1% penicillin/streptomycin (pen/strep, Gibco/Invitrogen), 1% glutamine (Gibco/Invitrogen) and 1% HEPES, pH 7 (Gibco/Invitrogen) and maintained at 37degreesC with 5% CO2.
###end p 52
###begin p 53
###xml 64 68 64 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Goncalves1">[34]</xref>
###xml 553 554 535 536 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 114 119 <span type="species:ncbi:10090">mouse</span>
Mouse primary hepatocytes were obtained as previously described [34]. Briefly, they were isolated by perfusion of mouse liver lobule with liver perfusion medium (Gibco/Invitrogen) and purified using a 1.12 g/ml; 1.08 g/ml and 1.06 g/ml Percoll gradient. Cells were cultured in William's E medium containing 4% FCS, 1% pen/strep, 50 mg/ml epidermal growth factor (EGF), 10 microg/ml transferrin, 1 microg/ml insulin and 3.5 microM hydrocortisone in 24 well plates coated with 0,2% Gelatine in PBS. Cells were maintained in culture at 37degreesC and 5% CO2.
###end p 53
###begin p 54
###xml 8 12 <span type="species:ncbi:10090">mice</span>
C57BL/6 mice, were bred in the pathogen-free facilities of the Instituto de Gulbenkian de Ciencia (IGC) and housed in the pathogen-free facilities of the Instituto de Medicina Molecular (IMM). All protocols were approved by the Animal Care Committees of both Institutes.
###end p 54
###begin p 55
###xml 43 53 43 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 89 93 89 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-FrankeFayard1">[35]</xref>
###xml 143 162 143 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Anopheles stephensi</italic>
###xml 43 53 <span type="species:ncbi:5821">P. berghei</span>
###xml 143 162 <span type="species:ncbi:30069">Anopheles stephensi</span>
Green fluorescent protein (GFP) expressing P. berghei (parasite line 259cl2) sporozoites [35] were obtained from dissection of infected female Anopheles stephensi mosquito salivary glands.
###end p 55
###begin title 56
siRNA design, siRNA library and screening controls
###end title 56
###begin p 57
###xml 40 48 40 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Silencer</italic>
###xml 454 462 454 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000201.s001">Table S1</xref>
###xml 338 343 <span type="species:ncbi:9606">human</span>
All siRNAs were purchased from Ambion's Silencer genome wide library (Ambion/Applied Biosystems, Austin USA). Each gene was targeted by using distinct siRNAs used individually in all cases. Negative control samples included untransfected cells, and cells transfected with a negative control siRNA not targeting any annotated genes in the human genome. A full list of gene names, siRNA ID numbers and sequences, and associated screening data are shown in Table S1.
###end p 57
###begin title 58
###xml 35 45 35 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
High-throughput siRNA screening of Plasmodium infection
###end title 58
###begin p 59
###xml 145 146 135 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 915 916 877 878 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 916 926 878 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 1270 1275 <span type="species:ncbi:10090">mouse</span>
###xml 1329 1333 <span type="species:ncbi:9925">goat</span>
###xml 1339 1344 <span type="species:ncbi:10090">mouse</span>
Huh7 cells (4500 per well) were seeded in 100 microl complete RPMI medium in optical 96-well plates (Costar) and incubated at 37degreesC in 5% CO2. Twenty-four h after seeding, cells were transfected with individual siRNAs in a final concentration of 100 nM per lipofection. Each siRNA was transfected in triplicate. Briefly, for each well, cell supernatant was replaced by 80 microl of serum-free culture medium without antibiotics. One microl of 10 microM siRNA diluted in 16 microl of Opti-MEM (Invitrogen) was complexed with 0.4 microl Oligofectamine (Invitrogen) diluted with 2.6 microl Opti-MEM and added onto the cells following the manufacturer's protocol. Four h after addition of the complex, 50 microl of fresh RPMI medium, supplemented with 30% FCS, 3% pen/strep, 3% non-essential amino acid, 3% glutamine and 3% HEPES were added to the cells. Two d after siRNA transfection, cells were infected with 104P. berghei sporozoites/well. Twenty-four h after infection, cells were fixed with 4% paraformaldehyde (PFA) in PBS and permeabilized with 0.2% saponin in PBS. Cell nuclei were stained with Hoechst-33342 (Molecular Probes/Invitrogen), filamentous actin was stained with Phalloidin AlexaFluor488 (Molecular Probes/Invitrogen), EEFs were detected using the mouse monoclonal antibody 2E6 and an AlexaFluor555 labeled goat anti-mouse secondary antibody (Molecular Probes/Invitrogen).
###end p 59
###begin title 60
Automated image acquisition and analysis
###end title 60
###begin p 61
###xml 680 681 676 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Plates were acquired with a Discovery1 automated fluorescence microscope (Molecular Devices Corporation, CA, USA) using a 10x lens. In each well, cell nuclei, actin and EEFs were imaged in 9 fields covering a total area of 2.7x2.0 mm. Image data was analyzed using a custom MetaMorph (Molecular Devices Corporation, CA, USA) based algorithm extracting the following values for each imaged field: cell proliferation as measured by the number of nuclei per imaged field (Hoechst staining), cell confluency as measured by the percentage of the imaged field covered by actin staining and number of EEFs as number of compact, high contrast objects in a size range from 16 to 150 microm2. Within each field, the number of EEFs was normalized to the cell confluency. Normalized EEF numbers and number of nuclei were averaged between the 9 imaged fields within each well. Mean and standard deviations were calculated for each experimental triplicate.
###end p 61
###begin title 62
Gene-specific expression and infection quantification by qRT-PCR
###end title 62
###begin p 63
###xml 29 37 29 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 874 910 870 906 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCT GGA GGA GAA GAG GAA AGA GA-3&#8242;</named-content>
###xml 915 954 911 950 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTG AGG ACC TCT GTG TAT TTG TCA A-3&#8242;</named-content>
###xml 997 1032 993 1028 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGG CTT AAT TTG ACT CAA CAC G-3&#8242;</named-content>
###xml 1037 1072 1033 1068 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTA GCA TGC CAG AGT CTC GTT C-3&#8242;</named-content>
For gene-specific expression in vitro, total RNA was isolated from Huh7 cells 48 h post-transfection (Invitek Invisorb 96-well plate kit) and converted into cDNA (ABI's HighCapacity cDNA reagents) with random hexamers, following the manufacturer recommendations. qRT-PCR used the SybrGreen method with Quantace qPCR mastermix at 11 microl total reaction volume, containing 500 nM of the target-specific primers, and primers that were designed to specifically amplify a fragment of the selected genes. Real-time PCR reactions were performed on an ABI Prism 7900HT system. Relative amounts of remaining mRNA levels of RNAi targets were calculated against the level of RPL13A or 18S rRNA, as housekeeping genes. Remaining mRNA levels of RNAi-treated samples were compared with those of samples transfected with Negative unspecific siRNA. RPL13A-specific primer sequences were: 5'-CCT GGA GGA GAA GAG GAA AGA GA-3' and 5'-TTG AGG ACC TCT GTG TAT TTG TCA A-3'. 18S rRNA-specific primer sequences were: 5'-CGG CTT AAT TTG ACT CAA CAC G-3' and 5'-TTA GCA TGC CAG AGT CTC GTT C-3'.
###end p 63
###begin p 64
###xml 28 35 28 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 39 46 39 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 246 253 246 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 307 316 307 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. yoelii</italic>
###xml 328 332 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-BrunaRomero1">[36]</xref>
###xml 1397 1445 1382 1430 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- AAG CAT TAA ATA AAG CGA ATA CAT CCT TAC &#8211; 3&#8242;</named-content>
###xml 1450 1493 1435 1478 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; - GGA GAT TGG TTT TGA CGT TTA TGT G &#8211; 3&#8242;</named-content>
###xml 1498 1534 1483 1519 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; &#8211; TGC TCG AGA TGT GAT GAA GG &#8211; 3&#8242;</named-content>
###xml 1539 1575 1524 1560 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; &#8211; TCC CCT GTT GAC TGG TCA TT &#8211; 3&#8242;</named-content>
###xml 1580 1616 1565 1601 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; &#8211; TGC TCG AGA TGT GAT GAA GG &#8211; 3&#8242;</named-content>
###xml 1621 1657 1606 1642 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; &#8211; TCC CCT GTT GAC TGG TCA TT &#8211; 3&#8242;</named-content>
###xml 307 316 <span type="species:ncbi:5861">P. yoelii</span>
###xml 1345 1350 <span type="species:ncbi:10090">mouse</span>
###xml 1355 1360 <span type="species:ncbi:9606">human</span>
###xml 1784 1789 <span type="species:ncbi:10090">Mouse</span>
For infection determination in vivo or ex vivo, total RNA was isolated from livers or primary hepatocytes using Qiagen's RNeasy Mini or Micro kits, respectively, following the manufacturer's instructions. The determination of liver parasite load in vivo, was performed according to the method developed for P. yoelii infections [36]. Livers were collected and homogenized in denaturing solution (4 M guanidine thiocyanate; 25 mM sodium citrate pH 7, 0.5% sarcosyl and 0.7% beta-Mercaptoethanol in DEPC-treated water), 40 h after sporozoite injection. Total RNA was extracted using Qiagen's RNeasy Mini kit, following the manufacturer's instructions. RNA for infection measurements was converted into cDNA using Roche's Transcriptor First Strand cDNA Synthesis kit, according to the manufacturer's protocol. The qRT-PCR reactions used Applied Biosystems' Power SYBR Green PCR Master Mix and were performed according to the maunufacturer's instructions on an ABI Prism 7000 system (Applied Biosystems). Amplification reactions were carried out in a total reaction volume of 25 microl, containing 0,8 pmoles/microl or 0,16 pmoles/microl of the PbA 18 S- or housekeeping gene-specific primers, respectively. Relative amounts of PbA mRNA were calculated against the Hypoxanthine Guanine Phosphoribosyltransferase (HPRT) housekeeping gene. PbA 18 S-, mouse and human HPRT-specific primer sequences were 5'- AAG CAT TAA ATA AAG CGA ATA CAT CCT TAC - 3' and 5' - GGA GAT TGG TTT TGA CGT TTA TGT G - 3' and 5' - TGC TCG AGA TGT GAT GAA GG - 3' and 5' - TCC CCT GTT GAC TGG TCA TT - 3' and 5' - TGC TCG AGA TGT GAT GAA GG - 3' and 5' - TCC CCT GTT GAC TGG TCA TT - 3', respectively. For PKCzeta mRNA level determination by qRT-PCT, PKCzeta-specific primers were used (RT2 qPCR Primer Assay for Mouse Prkcz, SuperArray Bioscience Corporation).
###end p 64
###begin title 65
Pseudosubstrate inhibition of PKCzeta
###end title 65
###begin p 66
Inhibition of PKCzeta was carried out by incubation of the cells with a myristoylated PKCzeta peptide (myr-SIYRRGARRWRKLYRAN), whose sequence corresponds to that of a pseudosubstrate inhibitor of the enzyme. A myristoylated scrambled peptide (myr- RLRYRNKRIWRSAYAGR) was used as a control in these experiments.
###end p 66
###begin p 67
###xml 269 270 269 270 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 272 273 272 273 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 611 617 <span type="species:ncbi:9986">rabbit</span>
In order to determine the specificity of the pseudosubstrate inhibitor, Huh7 cells were incubated overnight with either scrambled or pseudosubstrate peptides and then harvested in modified RIPA buffer (150 mM NaCl; 50 mM Tris, pH 7.5; 1% Triton X100; 50 mM NaF; 1 mM Na3VO4; complete EDTA-free protease inhibitor cocktail). After migration on a 10% Tris-glycine gel, proteins were transferred to a nitrocellulose membrane (BIO-RAD), which was probed with anti-phospho-PKC (pan) (betaII Ser660) (Cell Signaling Technology) or anti-phospho-aPKC (Thr555/PKCiota; Thr560/PKCzeta) (Upstate) plus HRP-conjugated anti-rabbit (Amersham). The membrane was developed with the SuperSignal West Pico Chemiluminescent Subtrate (Pierce).
###end p 67
###begin p 68
###xml 85 91 82 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 589 595 565 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
To further evaluate the specificity of the pseudosubstrate inhibitor towards PKCzeta versus PKCiota, Huh7 cells were transfected (Lipofectamine 2000, Invitrogen) with plasmids encoding GFP-PKCzeta or GST-PKCiota . Forty eight hours after transfection the cells were incubated with either scrambled or pseudosubstrate peptides for 1 hour and then harvested as before. The relative expression levels of GFP-PKCzeta and GST-PKCiota were determined by probing the membrane with anti-aPKCzeta (C20, Santa Cruz Biotechnology), which recognizes the two isoenzymes. The % of inhibition of PKCzeta versus PKCiota was calculated from the anti-phospho-aPKC signals. All signals were normalized to those of actin.
###end p 68
###begin title 69
Fluorescence Activated Cell Sorting (FACS) analysis
###end title 69
###begin p 70
###xml 456 460 456 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000201-Prudencio2">[20]</xref>
FACS analysis at 2 and 24 after sporozoite addition was performed to determine the percentage of parasite-containing cells and parasite-GFP intensity within infected cells. For infection level measurement at 2 h, 1 mg/ml Dextran tetramethylrhodamine 10,000 MW, lysine fixable (fluoro-ruby) (Molecular Probes/ Invitrogen) was added to the cells immediately prior to sporozoite addition. Cell samples for FACS analysis were processed as previously described [20].
###end p 70
###begin title 71
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo RNAi
###end title 71
###begin p 72
###xml 232 262 229 259 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGGAcAGcAAcAAcuGcuudTsdT-3&#8242;</named-content>
###xml 274 304 271 301 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGccucAcAcGucuuAAAAdTsdT-3&#8242;</named-content>
###xml 316 345 313 342 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-cccuuAAcuAcAGcAuAuGdTsdT-3</named-content>
###xml 406 435 403 432 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- cuuAcGcuGAGuAcuucGATsT-3&#8242;</named-content>
###xml 614 615 611 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 615 625 612 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 570 574 <span type="species:ncbi:10090">mice</span>
###xml 710 714 <span type="species:ncbi:10090">mice</span>
###xml 821 825 <span type="species:ncbi:10090">mice</span>
###xml 1025 1029 <span type="species:ncbi:10090">mice</span>
C57Bl/6 mice (male, 6-8 weeks) were treated with a single intravenous (i.v.) administration of 5 mg/kg of siRNA formulated in liposomal nanoparticles (Alnylam). Three different modified siRNAs targeting PKCzeta were used: siRNA#1 - 5'-GGGAcAGcAAcAAcuGcuudTsdT-3'; siRNA#2 - 5'-GGccucAcAcGucuuAAAAdTsdT-3'; siRNA#3 - 5'-cccuuAAcuAcAGcAuAuGdTsdT-3. A modified siRNA targeting luciferase was used as control (5'- cuuAcGcuGAGuAcuucGATsT-3'). Lower case letters represent 2'OMe nucleotides and "s" represents phosphorothioate linkage. Thirty-six h after siRNA administration mice were infected by i.v. injection of 2x104P. berghei sporozoites. Remaining PKCzeta mRNA levels, parasite load in the livers of infected mice were determined by qRT-PCR 40 h after sporozoite injection, 76 h after siRNA administration. Infection of mice treated with one PKCzeta siRNA was allowed to proceed onto the blood stage and parasitemia (% of infected red blood cells) was measured daily. The PKCzeta protein level in the liver of siRNA-treated mice was determined by Western blot.
###end p 72
###begin title 73
Quantification of host PKCzeta protein expression in the liver
###end title 73
###begin p 74
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 131 137 <span type="species:ncbi:9986">rabbit</span>
###xml 242 248 <span type="species:ncbi:9986">rabbit</span>
###xml 281 287 <span type="species:ncbi:9986">rabbit</span>
###xml 288 299 <span type="species:ncbi:3704">horseradish</span>
PKCzeta protein level in the liver of mice treated with a PKCzeta siRNA was quantified by Western blot using the primary antibody (rabbit anti-PKCzeta (C20): sc-216, Santa Cruz Biotechnology) and normalised against actin level detected using rabbit anti-actin (A2066, Sigma). Anti-rabbit horseradish peroxidase-conjugated (NA934V, GE Healthcare, UK Ltd.) was used as secondary antibody. The membrane was developed using the ECL Western Blotting Analysis System, according to the manufacturer's instructions (Amersham Bioscience, Germany). Signal quantification was performed using the ImageJ software package (NIH, USA).
###end p 74
###begin title 75
Statistical analysis
###end title 75
###begin p 76
###xml 85 86 85 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 303 304 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 338 339 338 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
For samples in which n>5, statistical analyses were performed using unpaired Student t or ANOVA parametric tests. Normal distributions were confirmed using the Kolmogorov-Smirnov test. For samples in which n<5, statistical analyses were performed using Kruskall-Wallis or Wilcoxon non-parametric tests. p<0.05 was considered significant, p<0.001 was considered highly significant.
###end p 76
###begin title 77
Supporting Information
###end title 77
###begin p 78
List of siRNAs used throughout the RNAi screen. siRNAs that led to an increase or a decrease in infection are marked in red or in green, respectively. CN denotes the normalised number of nuclei in each condition. Genes in italics are those for which one siRNA met the selection criteria but all three siRNAs used in Pass 1 gave a statistically significant (p<0,05) difference in terms of infection rate. For these genes, the three siRNAs used in Pass 1 were used again in Pass 2.
###end p 78
###begin p 79
(0.07 MB PDF)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin p 81
###xml 242 252 239 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 242 252 <span type="species:ncbi:5821">P. berghei</span>
Infected cells following knock-down of hit genes identified in the RNAi screen. Representative pictures of cells transfected with siRNAs targeting MET, PRKWNK1, SGK2, STK35, PKCzeta and a Negative control siRNA, 24 hours after infection with P. berghei sporozoites. The pictures depict nuclei (in blue), actin (in red) and EEFs (in green) and show that cell confluency and morphology are not affected by gene knock-down whereas infection is decreased in all cases.
###end p 81
###begin p 82
(0.68 MB PDF)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin p 84
RNAi screen data analysed in terms of gene classification and gene ontology. (A) Data analysis according to distribution through kinase and kinase-related families. (B) Data analysis according to gene ontology and molecular function. (C) Gene ontology enrichment analysis of 3 RNAi screens showing only significantly enriched kinases (p<0.05). Spheres on Pass 3 pie plots denote the 5 kinases identified in the RNAi screen.
###end p 84
###begin p 85
(0.13 MB PDF)
###end p 85
###begin p 86
Click here for additional data file.
###end p 86
###begin p 87
Specificity of inhibition by PKCzInh. (A) Specificity of inhibition of atypical PKCs versus conventional and novel PKCs by PKCzInh. Cells treated with PKCzInh or with an equivalent amount of a scrambled peptide control, were probed with an antibody that specifically recognises the autophosphorilated form of atypical PKCs (Thr560 on PKCzeta; Thr555 on PKCiota) (top). In parallel, treated cells were incubated with phospho-PKC (pan), an antibody that specifically recognises the autophosphorilated form of conventional and novel PKCs (Ser660 on the hidrophobic site) (bottom). When at least 10 microM PKCzInh were used, a clear decrease in the intensity of the band corresponding to the atypical PKCs is observed while no difference is observed in the bands corresponding to the conventional and novel PKCs, showing that PKCzInh specifically inhibits atypical PKCs and has no effect on other PKCs. (B) Specificity of inhibition between atypical PKCs (PKCzeta versus PKCiota) by PKCzInh. To distinguish between PKCzeta and PKCiota, Huh7 cells were transfected with plasmids expressing either a tagged version of PKCzeta or a tagged version of PKCiota. The tag in either construct enables the overexpressed protein to be distinguished from the endogenous ones on SDS-PAGE, and the degree of autophosphorilation of each of the atypical PKCs to be analysed independently. The expression level of PKCzeta is approximately 5-fold higher than that of PKCiota, as shown by quantification of signal intensity of the two proteins following probing with an antibody that recognises both isoforms (left). Inhibition on those cells was only observed when 60 microM PKCzInh was used. Inhibition levels of PKCzeta (middle) and PKCiota (right) were assessed by probing with an antibody that specifically recognises the autophosphorilated form of atypical PKCs. The relative specificities of PKCzInh for the two isoforms were determined by calculating the percentage of inhibition of autophosphorilation of each of them and correcting for the difference in their expression levels. Our results show that the inhibitory effect on PKZzeta is approximately 2-fold that observed for PKCiota.
###end p 87
###begin p 88
(0.16 MB PDF)
###end p 88
###begin p 89
Click here for additional data file.
###end p 89
###begin p 90
###xml 116 121 <span type="species:ncbi:10090">mouse</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
PKCzeta in vivo knock-down does not cause any detectable or significant signs of Interferon or toxicity response on mouse livers. Effect of siRNA-mediated in vivo knock-down of PKCzeta on expression of interferon or toxicity-related genes measured by qRT-PCR. Each individual graph shows expression data for one gene indicated on top. For each siRNA, RNA extracts from liver samples of 3 different mice were tested in duplicate. The same set of samples, taken 48 h after sporozoite i.v. infection was used for the entire data set. Average and SD were normalized to the expression level of Rpl13a as housekeeper. Interferon response markers: Ifna1,interferon alpha1; ifnb1, interferon beta1; Ifi44, interferon-induced protein 44; Ifit1 and 2, interferon-induced protein(s) with tetratricopeptide repeats 1 and 2; Irf7, interferon regulatory factor 7; Mx1, myxovirus resistance 1; Oas2, oligoadenylate synthetase 2; Stat1, signal transducer and activator of transcription 1. Toxicity response markers: Bax, Bcl2-associated X protein; Bcl2l11, BCL2-like 11; Fos, FBJ osteosarcoma oncogene; Fosl1; fos-like antigen 1; Fyb, FYN binding protein; Gadd45a, growth arrest and DNA-damage-inducible 45 alpha; Gapdh, glyceraldehyde-3-phosphate dehydrogenase; Hspa5, heat shock protein 5; Il18, interleukine 18; Jun, Jun oncogene; Mapk3, mitogen activated protein kinase 3; Myc, myelocytomatosis oncogene.
###end p 90
###begin p 91
(0.07 MB PDF)
###end p 91
###begin p 92
Click here for additional data file.
###end p 92
###begin p 93
###xml 213 217 <span type="species:ncbi:10090">Mice</span>
###xml 423 427 <span type="species:ncbi:10090">mice</span>
Effect of siRNA-mediated in vivo silencing of PKCzeta on PKCzeta protein levels. The PKCzeta protein levels were measured by Western blot analysis of liver extracts collected 40 h after sporozoite i.v. injection. Mice were infected 36 h after RNAi treatment with siRNA #1. The plot shows the quantification of the amounts of PKCzeta normalised to those of actin (used as a housekeeping control protein) in liver samples of mice treated with the siRNA targeting the PKCzeta gene, relative to the normalised amounts of PKCzeta in control samples.
###end p 93
###begin p 94
(0.03 MB PDF)
###end p 94
###begin p 95
Click here for additional data file.
###end p 95
###begin p 96
We thank Gerard Manning for valuable help on the Kinome classification and Nuno Carmo and Luis Santos for technical assistance. We are extremely grateful to Geert-Jan van Gemert for his outstanding technical expertise.
###end p 96
###begin title 97
References
###end title 97
###begin article-title 98
The silent path to thousands of merozoites: the Plasmodium liver stage.
###end article-title 98
###begin article-title 99
Migration of Plasmodium sporozoites through cells before infection.
###end article-title 99
###begin article-title 100
Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids.
###end article-title 100
###begin article-title 101
Signaling-2000 and beyond.
###end article-title 101
###begin article-title 102
Minimizing the risk of reporting false positives in large-scale RNAi screens.
###end article-title 102
###begin article-title 103
###xml 37 42 <span type="species:ncbi:9606">human</span>
The protein kinase complement of the human genome.
###end article-title 103
###begin article-title 104
Genome-wide RNAi screen for host factors required for intracellular bacterial infection.
###end article-title 104
###begin article-title 105
Crosstalk between PKCzeta and the IL4/Stat6 pathway during T-cell-mediated hepatitis.
###end article-title 105
###begin article-title 106
Cross-talk between protein kinases Czeta and B in cyclic AMP-mediated sodium taurocholate co-transporting polypeptide translocation in hepatocytes.
###end article-title 106
###begin article-title 107
The extended protein kinase C superfamily.
###end article-title 107
###begin article-title 108
The atypical protein kinase Cs. Functional specificity mediated by specific protein adapters.
###end article-title 108
###begin article-title 109
###xml 38 41 <span type="species:ncbi:10116">rat</span>
Protein kinase C zeta subspecies from rat brain: its structure, expression, and properties.
###end article-title 109
###begin article-title 110
###xml 120 125 <span type="species:ncbi:10090">mouse</span>
A new member of the third class in the protein kinase C family, PKC lambda, expressed dominantly in an undifferentiated mouse embryonal carcinoma cell line and also in many tissues and cells.
###end article-title 110
###begin article-title 111
PKCzeta at the crossroad of NF-kappaB and Jak1/Stat6 signaling pathways.
###end article-title 111
###begin article-title 112
The PAR-aPKC system: lessons in polarity.
###end article-title 112
###begin article-title 113
Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm.
###end article-title 113
###begin article-title 114
Protein kinase C contains a pseudosubstrate prototope in its regulatory domain.
###end article-title 114
###begin article-title 115
Evidence of zeta protein kinase C involvement in polymorphonuclear neutrophil integrin-dependent adhesion and chemotaxis.
###end article-title 115
###begin article-title 116
###xml 110 113 <span type="species:ncbi:10116">rat</span>
Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport.
###end article-title 116
###begin article-title 117
Dissecting in vitro host cell infection by Plasmodium sporozoites using flow cytometry.
###end article-title 117
###begin article-title 118
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics.
###end article-title 118
###begin article-title 119
Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway.
###end article-title 119
###begin article-title 120
Host SR-BI plays a dual role in the establishment of malaria liver infection.
###end article-title 120
###begin article-title 121
Hepatocyte growth factor and its receptor are required for malaria infection.
###end article-title 121
###begin article-title 122
HGF/MET signalling protects Plasmodium-infected host cells from apoptosis.
###end article-title 122
###begin article-title 123
WNK1 and OSR1 regulate the Na+, K+, 2Cl- cotransporter in HeLa cells.
###end article-title 123
###begin article-title 124
The serine/threonine kinases SGK2 and SGK3 are potent stimulators of the epithelial Na+ channel alpha,beta,gamma-ENaC.
###end article-title 124
###begin article-title 125
K+ channel activation by all three isoforms of serum- and glucocorticoid-dependent protein kinase SGK.
###end article-title 125
###begin article-title 126
WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1.
###end article-title 126
###begin article-title 127
Exposure of Plasmodium sporozoites to the intracellular concentration of potassium enhances infectivity and reduces cell passage activity.
###end article-title 127
###begin article-title 128
Clik1: a novel kinase targeted to actin stress fibers by the CLP-36 PDZ-LIM protein.
###end article-title 128
###begin article-title 129
Regulation of innate immune response by MAP kinase phosphatase-1.
###end article-title 129
###begin article-title 130
###xml 70 87 <span type="species:ncbi:11103">hepatitis C virus</span>
Mitogen-activated protein kinase signalling pathways triggered by the hepatitis C virus envelope protein E2: implications for the prevention of infection.
###end article-title 130
###begin article-title 131
###xml 22 28 <span type="species:ncbi:10090">murine</span>
Improved isolation of murine hepatocytes for in vitro malaria liver stage studies.
###end article-title 131
###begin article-title 132
###xml 2 20 <span type="species:ncbi:5821">Plasmodium berghei</span>
A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle.
###end article-title 132
###begin article-title 133
###xml 37 41 <span type="species:ncbi:10090">mice</span>
Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR.
###end article-title 133
###begin p 134
The authors have declared that no competing interests exist.
###end p 134
###begin p 135
The work was supported by European Science Foundation (EURYI to MMM), Howard Hughes Medical Institute and Fundacao para a Ciencia e Tecnologia (FCT) of the Portuguese Ministry of Science (grant PTDC/BIA-MIC/72211/2006 to MMM). MP, CDR, ER and CC were supported by FCT fellowships (BI/15849/2005, BD/14232/2003, BPD/35836/2007 and BPD/40965/2007, respectively). MMM is a Howard Hughes Medical Institute International Scholar.
###end p 135

